UBS Maintains Buy on Johnson & Johnson, Raises Price Target to $320
UBS Maintains Buy on Johnson & Johnson, Raises Price Target to $320
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day